Swiss regulator approves blood safety system from Cerus

08/19/2009 | Reuters

Swissmedic granted approval to Cerus' Intercept blood system, which inactivates viruses, bacteria and other blood-borne pathogens in blood components used for transfusion. The company said the approval allows Intercept-treated platelets to be stored for a week.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ